News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Al-Wakeel Yasir B.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
07/07/2023 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.
Txns:
| Sold 9,617 shares
@ $1.7523, valued at
$16.9k
|
|
03/21/2023 |
4
| Al-Wakeel Yasir B. (Director) has filed a Form 4 on MAXCYTE, INC.
Txns:
| Granted 40,000 options to buy
@ $4.19, valued at
$167.6k
|
|
02/24/2023 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.
Txns:
| Sold 9,026 shares
@ $1.7355, valued at
$15.7k
|
|
07/27/2022 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.
Txns:
| Granted 53,600 shares
@ $0 Granted 40,000 options to buy
@ $5.02, valued at
$200.8k
|
|
07/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/17/2022 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.
Txns:
| Granted 53,600 shares
@ $0 Granted 80,000 options to buy
@ $7.08, valued at
$566.4k
|
|
08/11/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/29/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
12/11/2020 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Kronos Bio, Inc.
Txns:
| Granted 72,422 shares
@ $0 Granted 108,633 options to buy
@ $30.94, valued at
$3.4M
|
|
10/16/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/08/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
05/06/2020 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Neon Therapeutics, Inc.
Txns:
| Disposed/sold 196,965 shares
@ $0 Disposed/sold 192,759 options to buy
@ $5.8, valued at
$1.1M
Disposed/sold 61,031 options to buy
@ $10.2, valued at
$622.5k
Disposed/sold 100,000 options to buy
@ $6.13, valued at
$613k
|
|
03/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/27/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2020 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Neon Therapeutics, Inc.
Txns:
| Granted 65,000 shares
@ $0 |
|
11/25/2019 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Neon Therapeutics, Inc.
Txns:
| Granted 75,000 shares
@ $0 |
|
03/01/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/18/2018 |
4
| Al-Wakeel Yasir B. (CFO) has filed a Form 4 on Neon Therapeutics, Inc.
Txns:
| Exercised 17,241 options to buy
@ $5.8, valued at
$100k
|
|
06/26/2018 |
3
| Al-Wakeel Yasir B. (CFO) has filed a Form 3 on Neon Therapeutics, Inc. |
02/10/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
|
|